These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1474 related articles for article (PubMed ID: 17676301)

  • 41. Effectiveness of adjuvant chemotherapy in transitional cell carcinoma of the urinary bladder with lymph node involvement and/or lymphovascular invasion treated by radical cystectomy.
    Park J; Park S; Song C; Doo C; Cho YM; Ahn H; Kim CS
    Urology; 2007 Aug; 70(2):257-62. PubMed ID: 17826485
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term oncological outcomes in women undergoing radical cystectomy and orthotopic diversion for bladder cancer.
    Stein JP; Penson DF; Lee C; Cai J; Miranda G; Skinner DG
    J Urol; 2009 May; 181(5):2052-8; discussion 2058-9. PubMed ID: 19286213
    [TBL] [Abstract][Full Text] [Related]  

  • 43. External validation of extranodal extension and lymph node density as predictors of survival in node-positive bladder cancer after radical cystectomy.
    Masson-Lecomte A; Vordos D; Hoznek A; Yiou R; Allory Y; Abbou CC; de la Taille A; Salomon L
    Ann Surg Oncol; 2013 Apr; 20(4):1389-94. PubMed ID: 23208127
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Plasmacytoid variant urothelial bladder cancer: is it time to update the treatment paradigm?
    Kaimakliotis HZ; Monn MF; Cary KC; Pedrosa JA; Rice K; Masterson TA; Gardner TA; Hahn NM; Foster RS; Bihrle R; Cheng L; Koch MO
    Urol Oncol; 2014 Aug; 32(6):833-8. PubMed ID: 24954925
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Radical cystectomy for superficial tumors in the BCG era].
    Huguet Pérez J; Palou J; Millán Rodríguez F; Villavicencio Mavrich H; Rodríguez JV
    Arch Esp Urol; 2002; 55(1):50-6. PubMed ID: 11957752
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Initial conservative treatment for grade 3 Ta-1 superficial bladder cancer].
    Fujimoto K; Chihara Y; Kondo H; Hirao Y
    Hinyokika Kiyo; 2006 Jun; 52(6):433-8. PubMed ID: 16848356
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of American Joint Committee on Cancer pathologic stage T3a versus T3b urothelial carcinoma: analysis of patient outcomes.
    Boudreaux KJ; Chang SS; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Clark PE
    Cancer; 2009 Feb; 115(4):770-5. PubMed ID: 19152431
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Is Immediate Radical Cystectomy Necessary for All Patients with Non-Muscle-Invasive Micropapillary Bladder Cancer?
    Jackson BL; Mohammed A; Mayer N; Dormer J; Griffiths TR
    Urol Int; 2016; 96(1):32-8. PubMed ID: 25924623
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oncological and functional outcome of radical cystectomy in patients with bladder cancer and obstructive uropathy.
    Gupta NP; Kolla SB; Seth A; Hemal AK; Dogra PN; Kumar R
    J Urol; 2007 Oct; 178(4 Pt 1):1206-11; discussion 1211. PubMed ID: 17698145
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neoadjuvant cisplatin chemotherapy before radical cystectomy in invasive transitional cell carcinoma of the bladder: a prospective randomized phase III study.
    Martinez-Piñeiro JA; Gonzalez Martin M; Arocena F; Flores N; Roncero CR; Portillo JA; Escudero A; Jimenez Cruz F; Isorna S
    J Urol; 1995 Mar; 153(3 Pt 2):964-73. PubMed ID: 7853584
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Outcomes in patients with pathological carcinoma in situ only disease at radical cystectomy.
    Hassan JM; Cookson MS; Smith JA; Johnson DL; Chang SS
    J Urol; 2004 Sep; 172(3):882-4. PubMed ID: 15310989
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Radical radiotherapy and salvage cystectomy as the primary management of transitional cell carcinoma of the bladder. Results following the introduction of a CT planning technique.
    Borgaonkar S; Jain A; Bollina P; McLaren DB; Tulloch D; Kerr GR; Howard GC
    Clin Oncol (R Coll Radiol); 2002 Apr; 14(2):141-7. PubMed ID: 12069124
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recurrence-free survival after radical cystectomy of patients downstaged by transurethral resection.
    Nielsen ME; Bastian PJ; Palapattu GS; Trock BJ; Schoenberg MP; Chan T; Rogers CG
    Urology; 2007 Dec; 70(6):1091-5. PubMed ID: 18158024
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Outcomes of radical cystectomy and bladder preservation treatment for muscle-invasive urothelial carcinoma of the bladder.
    Supit W; Mochtar CA; Santoso RB; Umbas R
    Asian J Surg; 2014 Oct; 37(4):184-9. PubMed ID: 24637186
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transitional cell carcinoma involving the prostate: a clinicopathological retrospective study of 76 cases.
    Njinou Ngninkeu B; Lorge F; Moulin P; Jamart J; Van Cangh PJ
    J Urol; 2003 Jan; 169(1):149-52. PubMed ID: 12478124
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Selective bladder conservation using transurethral resection, chemotherapy, and radiation: management and consequences of Ta, T1, and Tis recurrence within the retained bladder.
    Zietman AL; Grocela J; Zehr E; Kaufman DS; Young RH; Althausen AF; Heney NM; Shipley WU
    Urology; 2001 Sep; 58(3):380-5. PubMed ID: 11549485
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transitional cell carcinoma of the bladder in young adults: presentation, natural history and outcome.
    Yossepowitch O; Dalbagni G
    J Urol; 2002 Jul; 168(1):61-6. PubMed ID: 12050493
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Delaying radical cystectomy for muscle invasive bladder cancer results in worse pathological stage.
    Chang SS; Hassan JM; Cookson MS; Wells N; Smith JA
    J Urol; 2003 Oct; 170(4 Pt 1):1085-7. PubMed ID: 14501697
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Is stage pT4a (D1) reliable in assessing transitional cell carcinoma involvement of the prostate in patients with a concurrent bladder cancer? A necessary distinction for contiguous or noncontiguous involvement.
    Pagano F; Bassi P; Ferrante GL; Piazza N; Abatangelo G; Pappagallo GL; Garbeglio A
    J Urol; 1996 Jan; 155(1):244-7. PubMed ID: 7490845
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer.
    Boudreaux KJ; Clark PE; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Chang SS
    J Urol; 2009 Feb; 181(2):540-5; discussion 546. PubMed ID: 19084855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 74.